Celldex Therapeutics (CLDX) EBIT Margin (QoQ) (2010 - 2026)
Celldex Therapeutics (CLDX) EBIT Margin (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Celldex Therapeutics | 1.72 Mn | 1.72 Mn | -1.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -49.09 Mn |
| Jun 30, 2025 | 27,966.00 |
| Mar 31, 2025 | -425,894.00 |
| Dec 31, 2024 | -313,472.00 |
| Sep 30, 2024 | 22,063.00 |
| Jun 30, 2024 | 2.42 Mn |
| Mar 31, 2024 | -2.49 Mn |
| Dec 31, 2023 | 156,554.00 |
| Sep 30, 2023 | 967,147.00 |
| Jun 30, 2023 | -903,201.00 |
| Mar 31, 2023 | -162,914.00 |
| Dec 31, 2022 | 507,615.00 |
| Sep 30, 2022 | 1.55 Mn |
| Jun 30, 2022 | -896,274.00 |
| Mar 31, 2022 | -727,627.00 |
| Dec 31, 2021 | 752,064.00 |
| Sep 30, 2021 | -1.32 Mn |
| Jun 30, 2021 | 204,284.00 |
| Mar 31, 2021 | -177,451.00 |
| Dec 31, 2020 | 149,246.00 |